NCT06930560 · RECRUITING
HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms
This trial is testing a hearing care program for people who already have Alzheimer's disease or a related dementia and also have untreated hearing loss. The program combines a hearing device with behavioral coaching and looks at whether addressing hearing loss reduces neuropsychiatric symptoms like agitation or anxiety, and eases stress on caregivers. It is a Phase NA trial, meaning it is evaluating a practical intervention rather than a drug, not yet proven or widely adopted.
You may qualify if
- Age 60 - 100 years old
- English-speaking
- Diagnosis of probable Alzheimer's Disease or other related dementia according to the core clinical criteria outlined in the National Institute on Aging (NIA) and Alzheimer's Association Guidelines
- Speech frequency pure tone average (0.5- 4 kHz) >25 db in the better-hearing ear; adult onset hearing loss
- Availability of caregiver/study partner who is 18+ to participate in all study-related visits and who provides care supervision
- Stable (for 2 weeks or longer) dosing of medication (e.g. antidepressants, antipsychotics) for neuropsychiatric symptoms
You're excluded if
- Current self-reported use of hearing aid or amplification device
- Medical contraindication to use hearing aids ( e.g. draining ears)
- Inability to participate in the 1-month follow up
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2025-11-24